Count on us for updates on the coronavirus and guidance for cancer patients and family members.Read the latest articles
Lynn Bailey is small lymphocytic leukemia (SLL) patient from Buffalo Gap, Texas diagnosed in 2013. He began treatment in January 2014 with lenalidomide (Revlimid) and rituximab (Rituxan). He was then switched to ibrutinib (Imbruvica) and rituximab in April 2014. He's now been on ibrutinib for over five years and is doing very well.